Search results for "HIF"

showing 10 items of 1515 documents

Femtosecond time resolved coherent anti-Stokes Raman spectroscopy: Experiment and modelization of speed memory effects on H2-N2 mixtures in the colli…

2005

194317; With the aim of temperature diagnostic, femtosecond time-resolved CARS (coherent anti-Stokes Raman spectroscopy) is applied to probe H2 in H2-N2 mixtures. In a first part, a Lorentzian profile is used to model the femtosecond CARS response. A difference between the experimental broadening and the expected one is observed in the collision regime. The observed broadening increases strongly in an inhomogeneous way with respect to the perturber concentration. This is of considerable importance for temperature measurements. In a second part, we show that in the collision regime, this inhomogeneous broadening is due to the speed dependence of the collisional parameters and the memory effe…

General Physics and Astronomy02 engineering and technology01 natural sciencesTemperature measurementVIBRATIONAL LINE-PROFILESsymbols.namesakeOpticsINDUCED POLARIZATION SPECTROSCOPYGAS-MIXTURES0103 physical sciencesSHIFTCARSCoherent anti-Stokes Raman spectroscopyPhysical and Theoretical Chemistry010306 general physicsTEMPERATUREH-2[PHYS.PHYS.PHYS-OPTICS]Physics [physics]/Physics [physics]/Optics [physics.optics][ PHYS.PHYS.PHYS-OPTICS ] Physics [physics]/Physics [physics]/Optics [physics.optics]CONSEQUENCESbusiness.industryChemistryTime resolved spectraCHANGING COLLISIONS021001 nanoscience & nanotechnologyCollisionDOPPLERFemtosecondRadiator (engine cooling)symbolsAtomic physics0210 nano-technologybusinessRaman spectroscopy
researchProduct

TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs).

2009

Abstract Oncogenic pathways underlying in the development of myelodysplastic syndromes (MDS) remain poorly characterized, but mutations of the ten-eleven translocation 2 (TET2) gene are frequently observed. In the present work, we evaluated the prognostic impact of TET2 mutations in MDS. Frameshift, nonsense, missense mutations, or defects in gene structure were identified in 22 (22.9%) of 96 patients (95% confidence interval [CI], 14.5-31.3 patients). Mutated and unmutated patients did not significantly differ in initial clinical or hematologic parameters. The 5-year OS was 76.9% (95% CI, 49.2%-91.3%) in mutated versus 18.3% (95% CI, 4.2%-41.1%) in unmutated patients (P = .005). The 3-year…

Genetic MarkersMalemedicine.medical_specialtyPathologyImmunologyBiochemistryGastroenterologyDisease-Free SurvivalFrameshift mutationDioxygenasesPredictive Value of TestsRisk FactorsInternal medicineProto-Oncogene ProteinsmedicineMissense mutationHumansAgedAged 80 and overUnivariate analysisProportional hazards modelbusiness.industryMyelodysplastic syndromesHazard ratioCell BiologyHematologyMiddle Agedmedicine.diseaseConfidence intervalDNA-Binding ProteinsSurvival RateInternational Prognostic Scoring SystemMyelodysplastic SyndromesMutationFemalebusinessFollow-Up StudiesBlood
researchProduct

Abstract 571: The shared mutation and neoantigen landscape of MMR-deficient colorectal cancers suggests immunoediting during tumor evolution

2019

Abstract The immune system can recognize and attack cancer cells and their precursors, especially those with a high load of mutation-induced neoantigens. Such neoantigens are particularly abundant in DNA mismatch repair (MMR)-deficient cancers. MMR deficiency results in microsatellite instability (MSI), which leads to multiple insertion/deletion mutations at coding microsatellites and to neoantigen-inducing translational frameshifts. The significance of immune selection and immunoediting potentially shaping the neoantigen landscape during the progression from premalignant MMR-deficient lesions into cancers has not yet been analyzed. We hypothesized that the neoantigen landscape of MSI cance…

Genetics0303 health sciencesCancer ResearchMutationCancerMicrosatellite instabilityHuman leukocyte antigenBiologymedicine.diseasemedicine.disease_cause3. Good healthFrameshift mutation03 medical and health sciences0302 clinical medicineOncologyImmunoeditingmedicineDNA mismatch repairMutation frequency030304 developmental biology030215 immunologyCancer Research
researchProduct

Confirmation of EP300 gene mutations as a rare cause of Rubinstein-Taybi syndrome.

2007

The Rubinstein-Taybi syndrome (RSTS, MIM 180849), a dominant Mendelian disorder with typical face, short stature, skeletal abnormalities, and mental retardation, is usually caused by heterozygous mutations of the CREBBP gene, but recently, EP300 gene mutations were reported in three individuals. Using quantitative PCR (for the CREBBP and EP300 genes) and genomic sequencing (for the EP300 gene), we studied here 13 patients who had shown no mutation after genomic sequencing of the CREBBP gene in a previous investigation. Two new disease-causing mutations were identified, including a partial deletion of CREBBP and a 1-bp deletion in EP300, c.7100delC (p.P2366fsX2401). The 1-bp deletion represe…

GeneticsAdultRubinstein-Taybi SyndromeMutationRubinstein–Taybi syndromeAdolescentBiologyGene mutationmedicine.diseasemedicine.disease_causePhenotypeFrameshift mutationsymbols.namesakePhenotypeGeneticsMendelian inheritancesymbolsmedicineHumansFemaleEP300GeneE1A-Associated p300 ProteinGenetics (clinical)European journal of human genetics : EJHG
researchProduct

The Clinical Significance of Unknown Sequence Variants in BRCA Genes.

2010

Abstract: Germline mutations in BRCA1/2 genes are responsible for a large proportion of hereditary breast and/or ovarian cancers. Many highly penetrant predisposition alleles have been identified and include frameshift or nonsense mutations that lead to the translation of a truncated protein. Other alleles contain missense mutations, which result in amino acid substitution and intronic variants with splicing effect. The discovery of variants of uncertain/unclassified significance (VUS) is a result that can complicate rather than improve the risk assessment process. VUSs are mainly missense mutations, but also include a number of intronic variants and in-frame deletions and insertions. Over …

GeneticsCancer ResearchBRCA genesNonsense mutationReviewBiologylcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogenslcsh:RC254-282oncogenetic counselingFrameshift mutationintegrated modelsGermline mutationOncologyvariantRNA splicingMissense mutationClinical significanceAlleleGeneCancers
researchProduct

Putative Breast Cancer Driver Mutations in TBX3 Cause Impaired Transcriptional Repression

2015

The closely related T-box transcription factors TBX2 and TBX3 are frequently overexpressed in melanoma and various types of human cancers, in particular, breast cancer. The overexpression of TBX2 and TBX3 can have several cellular effects, among them suppression of senescence, promotion of epithelial–mesenchymal transition, and invasive cell motility. In contrast, loss of function of TBX3 and most other human T-box genes causes developmental haploinsufficiency syndromes. Stephens and colleagues (1), by exome sequencing of breast tumor samples, identified five different mutations in TBX3, all affecting the DNA-binding T-domain. One in-frame deletion of a single amino acid, p.N212delN, was ob…

GeneticsCancer Researchp21frameshift mutationin-frame deletionMelanomadriver mutationTBX3Biologylcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaselcsh:RC254-282Frameshift mutationbreast cancerBreast cancerOncologymedicinesomatic mutationsHaploinsufficiencyGeneTranscription factorLoss functionExome sequencingOriginal ResearchFrontiers in Oncology
researchProduct

A Novel Homozygous Mutation in the Solute Carrier Family 26 Member 7 Gene Causes Thyroid Dyshormonogenesis in a Girl with Congenital Hypothyroidism

2020

We investigated the genetic cause of thyroid dyshormonogenesis in a girl with congenital hypothyroidism. Genetic analysis showed that she was homozygous for a hitherto not described mutation (c.1432_1433delGT, p.V478KfsX11) in the solute carrier family 26 member 7 (SLC26A7) gene. SLC26A7 is proposed to be an anion transporter in the thyroid gland. The mutation leads to a frameshift and a premature stop codon. The predicted protein is truncated and very likely to be nonfunctional if it was expressed at all. In addition, in silico studies predict the mutation to be pathogenic.

GeneticsEndocrinology Diabetes and MetabolismThyroid030209 endocrinology & metabolismBiologymedicine.diseaseGenetic analysisCongenital hypothyroidismFrameshift mutationSolute carrier family03 medical and health sciences0302 clinical medicineEndocrinologymedicine.anatomical_structureThyroid dyshormonogenesis030220 oncology & carcinogenesisMutation (genetic algorithm)medicineGeneThyroid
researchProduct

Molecular basis of mucopolysaccharidosis type II: Mutations in the iduronate-2-sulphatase gene

1993

A number of mutations in the X-chromosomal human iduronate-2-sulphatase gene have now been identified as the primary genetic defect leading to the clinical condition known as Hunter syndrome or mucopolysaccharidosis type II. The mutations that are tabulated include different deletions, splice-site and point mutations. From the group of 319 patients thus far studied by Southern analysis, 14 have a full deletion of the gene and 48 have a partial deletion or other gross rearrangements. All patients with full deletions or gross rearrangements have severe clinical presentations. Twenty-nine different "small" mutations have so far been characterised in a total of 32 patients. These include 4 nons…

GeneticsMutationPoint mutationIduronate-2-sulfataseHunter syndromeIduronate SulfataseBiologymedicine.diseasemedicine.disease_causeMolecular biologyFrameshift mutationMutationGenotypeGeneticsmedicineHumansPoint MutationMissense mutationMucopolysaccharidosis type IIGene DeletionGenetics (clinical)Mucopolysaccharidosis IIHuman Mutation
researchProduct

A single nucleotide deletion at the C1 inhibitor gene as the cause of hereditary angioedema: insights from a Brazilian family

2011

To cite this article: Ferraro MF, Moreno AS, Castelli EC, Donadi EA, Palma MS, Arcuri HA, Lange AP, Bork K, Sarti W, Arruda LK. A single nucleotide deletion at the C1 inhibitor gene as the cause of hereditary angioedema: insights from a Brazilian family.Allergy 2011; 66: 1384–1390. Abstract Background:  Hereditary angioedema is an autosomal dominant disease characterized by episodes of subcutaneous and submucosal edema. It is caused by deficiency of the C1 inhibitor protein, leading to elevated levels of bradykinin. More than 200 mutations in C1 inhibitor gene have been reported. The aim of this study was to analyze clinical features of a large family with an index case of hereditary angioe…

GeneticsMutationbiologyAngioedemabusiness.industryImmunologyAutosomal dominant traitmedicine.diseasemedicine.disease_causeFrameshift mutationC1-inhibitorExonHereditary angioedemamedicinebiology.proteinImmunology and Allergymedicine.symptombusinessIndex caseAllergy
researchProduct

Familial hypobetalipoproteinemia: Analysis by next generation sequencing and identification of a novel frameshift mutation in the apoB gene

2017

GeneticsNutrition and DieteticsApob geneEndocrinology Diabetes and MetabolismFamilial HypobetalipoproteinemiaMedicine (miscellaneous)Identification (biology)BiologyCardiology and Cardiovascular MedicineDNA sequencingFrameshift mutationNutrition, Metabolism and Cardiovascular Diseases
researchProduct